According to filings with the U.S. Securities and Exchange Commission, Human Longevity is raising $22,500,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, David Karow played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Human Longevity
Human Longevity, Inc. (HLI) is the genomics-based, health intelligence company creating the world s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine. Our DNA determines so much about each of us, but other factors can also influence our health. HLI is focused on compiling and analyzing more genotypic and phenotypic data because the combination of both enables us to generate unprecedented insights and accelerate our understanding into what makes us who we are and what we can change for a life better lived.

To learn more about Human Longevity, visit http://www.humanlongevity.com/

Contact:
David Karow, Chief Executive Officer
844-838-3322
https://www.linkedin.com/in/david-karow-304b3a143/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.